局部万古霉素粉末与稀释聚维酮碘冲洗降低初次全膝关节置换术后早期假体周围关节感染率
该回顾性队列研究纳入在城市大学附属非营利骨科医院接受初次全膝关节置换术的患者,比较未实施万古霉素粉末与稀释聚维酮碘冲洗(VIP)方案前、仅高危患者接受VIP及所有患者接受VIP三个时期的早期假体周围关节感染发生率。结果显示VIP与早期感染率降低相关,高危组和全体风险组较未实施VIP前分别降低44.6%和56.4%(1.01% vs 0.56% vs 0.44%,P=0.0088)。
要点
- VIP使高危和全体风险初次全膝关节置换患者的早期假体周围关节感染率分别降低44.6%和56.4%(1.01% vs 0.56% vs 0.44%,P=0.0088)。
- 全体风险患者接受VIP后,感染相对风险较高危患者额外下降21.4%,但无统计学显著性(0.56% vs 0.44%,P=0.4212)。
- 三个VIP感染队列之间无人口学差异。
核心结论
- VIP与初次全膝关节置换术后早期假体周围关节感染发生率降低相关,且不依赖于术前风险。
研究设计与样本
- 回顾性审查城市大学附属非营利骨科医院的初次全膝关节置换感染数据库,涵盖未实施VIP方案前(2012年1月至2013年12月)、仅高危患者接受VIP(2014年1月至2015年12月)及所有患者接受VIP(2016年1月至2019年9月)三个时期。
主要发现
- 与未实施VIP前队列相比,VIP使高危队列和全体风险队列的早期初次全膝关节置换假体周围关节感染发生率分别降低44.6%和56.4%(1.01% vs 0.56% vs 0.44%,P=0.0088)。
- 全体风险患者接受VIP后,较高危患者接受VIP的假体周围关节感染相对风险额外下降21.4%,但未达统计学显著性(0.56% vs 0.44%,P=0.4212)。
- 三个VIP感染队列之间无人口学差异。
关键数值与推荐
- 假体周围关节感染的诊断标准采用国家医疗安全网络和肌肉骨骼感染学会指南。
临床怎么用
- 原文未据此给出推荐。
局限性
- 鉴于该研究为历史性队列研究,正在进行一项多中心随机对照试验以最终确认其疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vancomycin powder and dilute povidone-iodine lavage (VIP) was introduced to reduce the incidence of periprosthetic joint infection (PJI) in high-risk total knee arthroplasty (TKA) patients. We hypothesize that VIP can reduce the incidence of early PJI in all primary TKA patients, regardless of preoperative risk. METHODS: An infection database of primary TKAs performed before a VIP protocol was implemented (January 2012-December 2013), during a time when only high-risk TKAs received VIP (January 2014-December 2015), and when all TKAs received VIP (January 2016-September 2019) at an urban, university-affiliated, not-for-profit orthopedic hospital was retrospectively reviewed to identify patients with PJI. Criteria used for diagnosis of PJI were the National Healthcare Safety Network and Musculoskeletal Infection Society guidelines. RESULTS: VIP reduced early primary TKA PJI incidence in both the high-risk and all-risk cohorts compared with the pre-VIP cohort by 44.6% and 56.4%, respectively (1.01% vs 0.56% vs 0.44%, P = .0088). In addition, after introducing VIP to all-risk TKA patients, compared with high-risk TKA patients, the relative risk of PJI dropped an additional 21.4%, but this finding did not reach statistical significance (0.56% vs 0.44%, P = .4212). There were no demographic differences between the 3 VIP PJI cohorts. CONCLUSION: VIP is associated with a reduced early PJI incidence after primary TKA, regardless of preoperative risk. With the literature supporting its safety and cost-effectiveness, VIP is a value-based intervention, but given the nature of this historical cohort study, a multicenter randomized controlled trial is underway to definitively confirm its efficacy.
引用
- Buchalter DB, Kirby DJ, Teo GM, et al. Topical Vancomycin Powder and Dilute Povidone-Iodine Lavage Reduce the Rate of Early Periprosthetic Joint Infection After Primary Total Knee Arthroplasty. J Arthroplasty. 2020. PMID: 32919848. doi:10.1016/j.arth.2020.07.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。